Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes

Background: Liraglutide is the first glucagon-like peptide-1 receptor agonist (GLP-1 RA) based on the human GLP-1 sequence, with potential weight loss benefits, approved for the treatment of type 2 diabetes (T2D) mellitus. Herein, we aimed to assess the 5-year effectiveness of Liraglutide in the man...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Environ Res Public Health
Hlavní autoři: Mirabelli, Maria, Chiefari, Eusebio, Caroleo, Patrizia, Arcidiacono, Biagio, Corigliano, Domenica Maria, Giuliano, Stefania, Brunetti, Francesco Saverio, Tanyolaç, Sinan, Foti, Daniela Patrizia, Puccio, Luigi, Brunetti, Antonio
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6981922/
https://ncbi.nlm.nih.gov/pubmed/31892206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijerph17010207
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky